Dr. Anne Rimoin, a professor of epidemiology at UCLA, said that the Ebola virus spreads through direct contact with infected bodily fluids [1].
Understanding the mechanism of transmission is critical for public health efforts, as the virus targets the immune system and can lead to rapid systemic failure. Because the virus is highly infectious through minimal exposure, containment depends on strict isolation and fluid management [3].
Rimoin said the virus attacks the immune system, which prevents the body from fighting the infection. This biological assault allows the virus to spread quickly through the bloodstream, affecting multiple organs. The transmission occurs when the virus enters the body through broken skin or mucous membranes, typically via contact with the blood, secretions, or other bodily fluids of an infected person [1].
Historical data shows that approximately 20,000 Ebola cases have been recorded over the past four decades [4]. While many outbreaks have occurred in remote regions of Africa, the virus continues to pose a global threat. A recent outbreak in the Congo resulted in hundreds of cases and dozens of deaths [5].
Medical experts said that only a small amount of contact with an infected individual is needed to contract the disease [3]. This high level of transmissibility makes healthcare workers particularly vulnerable during outbreaks. To combat the virus, researchers are pursuing preventative measures, including a Canadian vaccine trial that includes 39 U.S. volunteers [6].
Rimoin said the focus remains on informing the public about how the virus functions to reduce panic and improve response times. By identifying the specific ways the virus interacts with human biology, scientists can better develop treatments that protect the immune system from the initial viral surge [1].
“Ebola spreads through direct contact with infected bodily fluids”
The persistence of Ebola outbreaks, combined with its ability to incapacitate the immune system with minimal exposure, underscores the necessity of global vaccine development. The transition from treating individual outbreaks to conducting international vaccine trials indicates a shift toward proactive prevention to stop the virus before it reaches urban centers.
